REPLIGEN CORP Increase (Decrease) in Other Operating Liabilities
REPLIGEN CORP (RGEN) reported Increase (Decrease) in Other Operating Liabilities of -$207.39 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2014-08-11
- REPLIGEN CORP increase (decrease) in other operating liabilities for the quarter ending 2014-06-30 was -$101.17K, a 110.82% decline year-over-year.
- REPLIGEN CORP increase (decrease) in other operating liabilities for the quarter ending 2014-03-31 was -$106.22K.
- REPLIGEN CORP increase (decrease) in other operating liabilities for the quarter ending 2013-12-31 was $711.39K.
- REPLIGEN CORP increase (decrease) in other operating liabilities for the quarter ending 2013-09-30 was $685.21K.
- REPLIGEN CORP increase (decrease) in other operating liabilities for fiscal 2013 was $1.20M.
- REPLIGEN CORP increase (decrease) in other operating liabilities for fiscal 2012 was -$1.11M.
- REPLIGEN CORP increase (decrease) in other operating liabilities for fiscal 2011 was -$58.28K, a 119048.98% decline from fiscal 2010.
- REPLIGEN CORP increase (decrease) in other operating liabilities for fiscal 2010 was $49.00.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2014-06-30 | -$101.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$207.39K 10-Q · filed 2014-08-11 | $504.00K derived: sum of 3 quarters · filed 2014-08-11 | $1.19M derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | -$106.22K 10-Q · filed 2014-05-09 | $605.18K derived: sum of 2 quarters · filed 2014-05-09 | $1.29M derived: sum of 3 quarters · filed 2014-05-09 | $2.23M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-12-31 | $711.39K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.40M derived: sum of 2 quarters · filed 2014-03-14 | $2.33M derived: sum of 3 quarters · filed 2014-08-11 | $1.20M 10-K · filed 2014-03-14 |
| 2013-09-30 | $685.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.62M derived: sum of 2 quarters · filed 2014-08-11 | $490.27K 10-Q · filed 2013-11-08 | $386.13K derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-06-30 | $934.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$194.94K 10-Q · filed 2014-08-11 | -$299.08K derived: sum of 3 quarters · filed 2014-08-11 | -$1.52M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | -$1.13M 10-Q · filed 2014-05-09 | -$1.23M derived: sum of 2 quarters · filed 2014-05-09 | -$2.45M derived: sum of 3 quarters · filed 2014-05-09 | -$2.31M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | -$104.14K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$1.32M derived: sum of 2 quarters · filed 2014-03-14 | -$1.18M derived: sum of 3 quarters · filed 2014-03-14 | -$1.11M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$1.08M derived: sum of 2 quarters · filed 2013-11-08 | -$1.01M 10-Q · filed 2013-11-08 | -$991.33K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $141.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $212.76K 10-Q · filed 2013-08-07 | $228.09K derived: sum of 3 quarters · filed 2014-03-14 | $231.88K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $70.97K 10-Q · filed 2013-05-07 | $86.29K derived: sum of 2 quarters · filed 2014-03-14 | $90.09K derived: sum of 3 quarters · filed 2014-03-14 | $82.45K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $15.32K derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $19.12K derived: sum of 2 quarters · filed 2014-03-14 | $11.49K 10-K · filed 2014-03-14 | -$21.35K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-09-30 | $3.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | -$3.84K 10-Q · filed 2011-11-09 | -$36.67K 10-Q · filed 2012-11-08 | -$39.82K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-06-30 | -$7.63K 10-Q · filed 2011-08-05 | -$40.47K 10-Q · filed 2012-08-09 | -$43.62K derived: sum of 3 quarters · filed 2014-03-14 | -$46.77K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-03-31 | -$32.84K 10-Q · filed 2012-05-10 | -$35.99K derived: sum of 2 quarters · filed 2014-03-14 | -$39.14K derived: sum of 3 quarters · filed 2014-03-14 | -$58.28K 10-K · filed 2013-03-15 |
| 2010-12-31 | -$3.15K derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | -$6.30K derived: sum of 2 quarters · filed 2014-03-14 | -$25.45K 10-K · filed 2014-03-14 | |
| 2010-09-30 | -$3.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | -$22.30K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$19.15K 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $49.00 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |